← SynDRA
CARBIDOPA ANHYDROUS
SynDRA canonical compound SYN0023488 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | DDC |
|---|
| Mechanism of action | Aromatic L-amino acid decarboxylase inhibitor |
|---|
| Indication | Parkinson's Disease |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- Aromatic L-amino acid decarboxylase inhibitor
- DDC INHIBITOR
- DOPA decarboxylase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- OPRD1
- NPY2R
- NPY1R
- MPHOSPH8
- MMP9
- MMP1
- MC5R
- MC4R
- MC3R
- MAPT
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LMNA
- KDM4A
- KCNH2
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HSD17B10
- HRH2
- HRH1
- HPGD
- HMGCR
- NR3C1
- OPRK1
- ADORA1
- OPRM1
- VDR
- USP1
- THPO
- TDP1
- TBXAS1
- TACR2
- TACR1
- SMN1
- SLCO1B3
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Dyskinesia Agents
- Antiparkinson Agents
- Aromatic Amino Acid Decarboxylase Inhibitors
- Central Nervous System Agents
- Dopamine Agents
- Enzyme Inhibitors
- Neurotransmitter Agents
- Aromatic Amino Acid Decarboxylation Inhibitor
- DOPA Decarboxylase Inhibitors
Cross-references
Synonyms
- CARBIDOPA
- CARBIDOPA AND LEVODOPA
- CARBIDOPA, LEVODOPA AND ENTACAPONE
- CARBILEV
- CREXONT
- DHIVY
- DUOPA
- LODOSYN
- Lodosyn
- PARCOPA
- RYTARY
- SINEMET
- carbidopa
- carbidopa hydrate
- lodosin
- (S)-Carbidopa
- lodosyn
- alpha-Methyldopahydrazine
- Carbidopa, l- anhydrous
- RYTARY COMPONENT CARBIDOPA
- DHIVY COMPONENT CARBIDOPA
- Carbidopa monohydrate
- MNX7R8C5VO
- Carbidopa hydrate
- STALEVO COMPONENT CARBIDOPA
- SINEMET COMPONENT CARBIDOPA
- IPX-203 COMPONENT CARBIDOPA
- CORBILTA COMPONENT CARBIDOPA
- CARBILEV COMPONENT CARBIDOPA
- KR87B45RGH
- LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT CARBIDOPA
- carbidopa (usp monograph)
- DOPASNAP COMPONENT CARBIDOPA
- carbidopa (usp-rs)
- DUOPA COMPONENT CARBIDOPA
- MK-486
- NSC 758190
- NSC 751137
- carbidopa (ep monograph)
Reported adverse events
- Hypersensitivity
- Rash
- Angioedema
- Ataxia
- Gastrointestinal pain
- Henoch-Schonlein purpura
- Constipation
- Dyskinesia
- Nausea
- Depression
- Asthenia
- Dizziness
Look up CARBIDOPA ANHYDROUS in the interactive SynDRA portal →